CVRx, Inc. Share Price

CVRx, Inc. Share Price

NASDAQ: CVRX | Micro Cap
$1.43
+$0.02 (1.42%) Last updated on 29 Oct, 2026 | 20:53 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

CVRx, Inc. Stock Performance

Open
$1.38
Prev. Close
$1.41
Circuit Range
N/A
Day Range
$1.38 - $1.42
Year Range
$1.25 - $11.30
Volume
2,207
Average Traded
$1.40

CVRx, Inc. Share Price Today

As of 29 October 2026, CVRx, Inc.'s share price is $1.43. The stock opened at $1.38, compared to its previous close of $1.41. During today's trading session, CVRx, Inc.'s share price traded between $1.38 and $1.42, with an average price of $1.40. Over the past 52 weeks, the stock has recorded a high of $11.30 and a low of $1.25. In terms of performance, CVRx, Inc.'s share price has declined by 80.90% over the last six months and is down 86.00% on a year-on-year basis.

CVRx, Inc. Share Price Chart

Line chart of the CVRx, Inc. price trend over the selected period. The price rose overall, ranging from 1.38 to 1.46, ending at 1.43.
$1.38$1.42
L
Show Current Price
H

CVRx, Inc. Stock Fundamentals & Key Indicators

Market Cap
$37.17M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.95
Revenue (TTM)
$56.65B
Return On Equity (TTM)
-260.45%
Profit Margin
-94.10%
Debt to Equity
2.94
Quarterly Earnings Growth YoY
-9.09%

CVRx, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$14.69$16.02$14.77$15.71
Net Profit-$12.87-$11.93-$13.12-$14.04
Net Profit Margin-87.61%-74.47%-88.83%-89.37%
Income ChangeN/A7.30%-9.97%-7.01%

CVRx, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$22.47$39.30$51.29$56.65
Net Profit-$41.43-$41.20-$59.97-$53.31
Net Profit Margin-184.38%-104.83%-116.92%-94.10%
Income ChangeN/A0.56%-45.56%11.11%

About CVRx, Inc.

CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.

CVRx, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$1.75
$1.42
-20.73%
Sep 2026
$2.98
$1.78
-41.09%
Aug 2026
$5.48
$3.03
-40.70%
Jul 2026
$5.14
$5.11
+0.10%
Jun 2026
$5.60
$5.11
-8.35%
May 2026
$7.75
$5.57
-25.34%
Apr 2026
$9.59
$7.46
-20.89%
Mar 2026
$8.02
$9.43
+15.56%
Feb 2026
$6.84
$8.16
+19.82%
Jan 2026
$7.14
$6.81
-4.22%
Dec 2025
$9.73
$7.11
-27.52%
Nov 2025
$10.52
$9.81
-3.63%

CVRX Share Price FAQs